Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Deepal Wakade"'
Autor:
Shelley J. E. Hwang, Benjamin Y. Kong, Shaun Chou, Deepal Wakade, Matteo S. Carlino, Pablo Fernandez-Penas
Publikováno v:
Case Reports in Medicine, Vol 2017 (2017)
There are reported cases of diphencyprone used in treating cutaneous metastases of melanoma. Here, we report a patient with previous primary melanoma on his left back treated with surgical excision and lymphadenectomy, followed by radiotherapy for th
Externí odkaz:
https://doaj.org/article/f98d184b71c246b39efb74e0ba84bbd8
Autor:
Deepal Wakade, Rachael Anforth, Cathy Y. Zhao, Giuliana Carlos, Shelley Ji Eun Hwang, Pablo Fernandez-Penas
Publikováno v:
Australasian Journal of Dermatology. 58:292-298
BACKGROUND/OBJECTIVES Various cutaneous side-effects have been reported with anti-melanoma systemic therapies. This study investigated the changes in melanocytic lesion pigmentation in patients on four different therapies. METHODS We analysed the ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4ccac1b39cc58b250b6a591cbdc7e8
https://doi.org/10.1111/ajd.12645
https://doi.org/10.1111/ajd.12645
Autor:
Pablo Fernandez-Penas, Rina Hui, Shelley Ji Eun Hwang, Giuliana Carlos, Shaun Chou, Deepal Wakade
Publikováno v:
Melanoma Research. 26:421-424
The introduction of immunotherapy such as antiprogrammed death1 (anti-PD1) monoclonal antibodies has changed the scenario of treatment in cancer. Apart from their impressive efficacy profiles, they are better tolerated than the anticytotoxic T-lympho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b848bd90b9889f2e6ac0212611d7884
https://doi.org/10.1097/cmr.0000000000000263
https://doi.org/10.1097/cmr.0000000000000263
Autor:
Shaun Chou, Benjamin Y. Kong, Shelley Ji Eun Hwang, Deepal Wakade, Pablo Fernandez-Penas, Matteo S. Carlino
Publikováno v:
Case Reports in Medicine, Vol 2017 (2017)
Case Reports in Medicine
Case Reports in Medicine
There are reported cases of diphencyprone used in treating cutaneous metastases of melanoma. Here, we report a patient with previous primary melanoma on his left back treated with surgical excision and lymphadenectomy, followed by radiotherapy for th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6de1191772a8b7f33db437e20b00ca5b
https://doi.org/10.1155/2017/5462929
https://doi.org/10.1155/2017/5462929
Autor:
Karen Byth, Pablo Fernandez-Penas, John J. Park, Shaun Chou, Shelley Ji Eun Hwang, Deepal Wakade
Publikováno v:
Melanoma research. 29(2)
To date, cutaneous toxicities of combination therapies of anti-programmed death-1 (anti-PD1) and ipilimumab are poorly described. Understanding cutaneous presentations will aid clinicians with early diagnoses and treatments. We aim to describe and co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7bfa948f30252179a5cceb2a3197b5
https://pubmed.ncbi.nlm.nih.gov/30273233
https://pubmed.ncbi.nlm.nih.gov/30273233
Publikováno v:
The American Journal of dermatopathology. 39(1)
Lichenoid drug reaction is a common adverse reaction in patients taking immune-modulatory agents such as antiprogramed cell death (PD-1) and cytotoxic T lymphocyte antigen-4 agents. The authors describe the clinical and histologic features of licheno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997178027c39966742fd17a0360b83b1
https://pubmed.ncbi.nlm.nih.gov/28045749
https://pubmed.ncbi.nlm.nih.gov/28045749
Autor:
Shelley Ji Eun Hwang, Shaun Chou, Matteo S. Carlino, Giuliana Carlos, Deepal Wakade, Pablo Fernandez-Penas
Publikováno v:
Melanoma research. 26(4)
Anti-programmed cell death 1 (anti-PD1) antibodies such as pembrolizumab have shown improved progression-free and overall survival in patients with advanced melanoma. Of 124 patients reviewed in Westmead Hospital from May 2012 to November 2015, treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa1b006afd9fe0994eb0ea84d9d954e
https://pubmed.ncbi.nlm.nih.gov/27031539
https://pubmed.ncbi.nlm.nih.gov/27031539
Publikováno v:
Melanoma research. 26(4)
Ipilimumab is a new anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody that stimulates the immune response against melanoma. A 50-year-old man received ipilimumab for metastatic melanoma as part of a clinical trial. Two weeks after drug initia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a3d8e3b483f36a87816e2fe78fdcb7
https://pubmed.ncbi.nlm.nih.gov/27031538
https://pubmed.ncbi.nlm.nih.gov/27031538
Autor:
Shelley Ji Eun Hwang, Pablo Fernandez-Penas, Giuliana Carlos, Deepal Wakade, Shaun Chou, Benjamin Y. Kong, Matteo S. Carlino, Richard F. Kefford, Karen Byth
Publikováno v:
Journal of the American Academy of Dermatology. 74:455-461.e1
Background Anti-programmed cell death (PD)-1 therapy is emerging as the backbone of new standard of care immunotherapy for metastatic melanoma. Immune-related cutaneous events are observed in these patients. Objective We sought to describe cutaneous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92a2b5632cf37f177d22b88fdbb8fcc
https://doi.org/10.1016/j.jaad.2015.10.029
https://doi.org/10.1016/j.jaad.2015.10.029